Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
High Plavix doses overcome genetic barrier-study
Reuters
Wed, 11/16/11 - 09:46 am
Plavix
bloodthinners
Sanofi
Bristol-Myers Squibb
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
Wed, 11/16/11 - 09:45 am
Bristol-Myers Squibb
earnings
Doctors reserve judgement on new blood clot drugs
Reuters
Tue, 11/15/11 - 12:36 pm
physicians
bloodthinners
Apixaban
Xarelto
Pradaxa
Bayer
Boehringer Ingelheim
JNJ
Pfizer
Bristol-Myers Squibb
Bristol, Pfizer clot drug fails to help ill patients
Reuters
Sun, 11/13/11 - 12:12 pm
Bristol-Myers Squibb
Pfizer
Eliquis
Apixaban
anticoagulants
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb
Healthcare Sector: Noteworthy Insider Buys And Sells
Seeking Alpha
Tue, 11/8/11 - 11:03 am
Alkermes
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
JNJ
United Health
Seattle Genetics
Pharmasset
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bloomberg
Mon, 11/7/11 - 09:15 pm
Erbitux
Bristol-Myers Squibb
ImClone
Eli Lilly
head and neck cancer
Will Bristol-Myers Squibb Earn or Burn?
Motley Fool
Thu, 11/3/11 - 11:35 am
Bristol-Myers Squibb
Teva Pharmaceuticals
Pfizer
Watson
Ranking Drug Company Dividend Stocks By Risk And Growth
Seeking Alpha
Tue, 11/1/11 - 06:14 pm
dividends
JNJ
Pfizer
Novartis
GSK
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Pharmasset
hepatitis C
Ribavirin
Vertex
Abbott Laboratories
PSI-7977
JNJ
Roche
Bristol-Myers Squibb
Why Bristol-Myers Is Not Overvalued
Seeking Alpha
Sun, 10/30/11 - 12:46 pm
Bristol-Myers Squibb
Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales
Seeking Alpha
Fri, 10/28/11 - 09:34 am
Vertex
earnings
hepatitis C
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
SciClone
Pharmasset
Bristol-Myers Tops Third-Quarter Profit Estimate
Bloomberg
Thu, 10/27/11 - 08:20 am
earnings
Bristol-Myers Squibb
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wed, 10/26/11 - 06:12 pm
Bristol-Myers Squibb
diabetes
FDA
AstraZeneca
Dapagliflozin
10 largest upcoming pharma patent losses in the US
Fierce Pharma
Tue, 10/25/11 - 11:54 am
Takeda
Actos
Forest Labs
Lexapro
Bristol-Myers Squibb
Plavix
AstraZeneca
Seroquel
Eli Lilly
Zyprexa
Pfizer
Lipitor
Merck
Singulair
Novartis
Diovan
Provigil
Teva Pharmaceuticals
Abbott Laboratories
TriCor
Forbes Earnings Preview: Bristol-Myers Squibb
Forbes
Mon, 10/24/11 - 10:35 pm
earnings
Bristol-Myers Squibb
Bristol-Myers Squibb Co. Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Mon, 10/24/11 - 04:06 pm
earnings
Bristol-Myers Squibb
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Abbott Laboratories
reorganization
Amgen
Biogen Idec
Bristol-Myers Squibb
GSK
JNJ
Boston Scientific
Medtronic
Pfizer
Roche
Pharmasset
Bristol-Myers, Sanofi $442 Million Plavix Award Upheld on Appeal
Bloomberg
Tue, 10/18/11 - 12:13 pm
Plavix
Sanofi
Bristol-Myers Squibb
patents
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Anadys
Roche
Merck
JNJ
Achillion
M&A
Indenix
Bristol-Myers Squibb
Pages
« first
‹ previous
…
82
83
84
85
86
87
88
89
90
…
next ›
last »